Core Wealth Advisors, Inc. Abb Vie Inc. Transaction History

Core Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $38,073 - $44,075	285 Added 459.68%	347 $51,000
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $8,575 - $10,283	62 New	62 $10,000
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $49,492 - $61,406	-375 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $40,286 - $50,973	375 New	375 $51,000
Q1 2021 May 04, 2021	SELL	$102.3 - $112.62 $40,920 - $45,048	-400 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $32,195 - $43,468	400 New	400 $43,000

3,795

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $353B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Core Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Core Wealth Advisors, Inc. with notifications on news.